XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.500
0.00 (0.00%)
Oct 23, 2026, 1:04 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 19.87 million as of October 23, 2026. It is the 43,825th most valuable company in the world and the 466th biggest in Israel. Its market cap has decreased by 47.58% in one year.
Market Cap
19.87M
Enterprise Value
19.62M
Revenue
n/a
Global Rank
Country Rank
#466 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 19.87M, a decrease of -97.53%. That is a compound annual growth rate of -16.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.87M | -12.52% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 209.10M |
| Matricelf | 82.54M |
| BioLineRx | 35.84M |
| Clal Biotechnology Industries | 34.51M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.55M |
| Evogene | 18.42M |
| Can-Fite BioPharma | 18.13M |